7Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis,2001,32:358-366. 被引量：1
8NCCLS. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS document M-38A. NCCLS,2002,18:1-29. 被引量：1
9Kamai Y, Chiang LY, Lopes Bezerra LM, et al. Interactions of Aspergillus fumigatus with vascular endothelial cells. Med Mycol, 2006, 44 : S115-S117. 被引量：1
10Lopes Bezerra LM, Filler SG. Interactions of Aspergillus fumigatus with endothelial ceils : internalization, injury, and stimulation of tissue factor activity. Blood, 2004,103:2143-2149. 被引量：1
1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
3Nucci M , Marr KA. Emerging fungal disease[J] . Clin Infect Dis ,2005 ,41 :5212526. 被引量：1
4Ress JR, Pinner RW, Hajjeh, et al. The ep idemiologi- cal feature of invasive mycotic infections in the San Francisco Bay area. 1992 - 1993:result of population - based laboratory active sureveillance. Clin Infect Dis, 1998, 27(5): 1138 - 1147. 被引量：1
5Fridkin SK, The changing face of fungal infections in health care settings[J]. Clin Infect Dis , 2005 , 41 : 145521466. 被引量：1
